备注:
库存充足,如需更大包装,请联系销售人员,大包装有极大的折扣优惠!
详细介绍
l 基本信息 |
产品名称 | 塞来昔布(Celecoxib) |
一般描述 | Celecoxib(塞来昔布)
is a pyrazole derivative and selective COX-2 inhibitor. |
别 称 | 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide; 塞来考昔
;Celebrex; Celebra; Onsenal; |
纯 度 | ≥99%(HPLC) | CAS NO. | 169590-42-5 |
分子式 | C17H14F3N3O2S | 分子量 | 381.373 |
适用范围 | 生物试剂,适用于细胞培养等 |
l 理化信息 |
外 观 | 白色至类白色固体 |
溶解性(25℃) | DMSO | ≥50mg/mL |
乙醇 | ≥25mg/mL |
水 | Insoluble |
l 生物学信息 |
生物活性/药理作用 | Celecoxib, a selective cyclooxygenase-2
(COX-2) inhibitor, is classified as a nonsteroidal anti-inflammatory drug
(NSAID). Celecoxib is used to treat rheumatoid arthritis, osteoarthritis, and
familial adenomatous polyposis (FAP). Because of its lack of platelet
effects, celecoxib is not a substitute for aspirin for cardiovascular
prophylaxis. It is not known if there are any effects of celecoxib on platelets that may contribute to the increased risk of serious cardiovascular thrombotic adverse events associated with the use of celecoxib. Inhibition of
PGE2 synthesis may lead to sodium and water retention through increased fluid
reabsorption in the renal medullary thick ascending loop of Henle and perhaps other segments of the distal nephron. In the collecting ducts, PGE2 appears
to inhibit water reabsorption by counteracting the action of antidiuretic hormone. Celecoxib is a nonsteroidal
anti-inflammatory drug (NSAID) with a diaryl-substituted pyrazole structure. Celecoxib selectively inhibits cyclo-oxygenase-2 activity (COX-2); COX-2
inhibition may result in apoptosis and a reduction in tumor angiogenesis and
metastasis. |
l 包装与存储 |
包 装 | 1g |
存储温度 | 0-5℃ |
l 注意事项及免责声明 |
本产品仅用于实验研究,不得作为药物使用,不得用于家用或其它用途。 |
l 参考文献 |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |